Dr. Ledermann on Systemic Treatment for Rare Gynecologic Tumors
Jonathan Ledermann, MD
Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, United Kingdom, discusses systemic treatment for patients with rare gynecologic tumors.
Rare tumors are the hardest ones to treat because less is understood about their biology and the current drugs are not as active in these tumors, explains Ledermann.
In order to understand the management of rare epithelial tumors, global collaborative studies are needed, says Ledermann.